| Financial Year |
March 31 2023 |
| Monetary Funds |
933,575,570.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
136,475,679.91 |
| Accounts Receivable |
853,915,286.80 |
| Advances to Suppliers |
54,722,581.71 |
| Other Receivables |
2,533,825.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
536,565,640.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,671,842.85 |
| Total Current Assets |
2,585,498,375.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
45,018,339.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,233,710.60 |
| R&D expenses |
24,706,646.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,104,427.32 |
| Deferred Income Tax Assets |
10,517,306.21 |
| Other Non-Current Assets |
10,034,945.27 |
| Sub-Total of Non-Current Assets |
150,763,240.33 |
| Total Assets |
2,736,261,615.85 |
| Short-Term Loans |
125,146,250.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,258,571.74 |
| Accounts Payable |
245,305,803.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,263,868.64 |
| Taxes Payable |
16,514,464.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,854,764.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,432,254.90 |
| Other Current Liabilities |
40,558,647.94 |
| Sub-Total of Current Liabilities |
543,097,075.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,969,495.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,815,435.06 |
| Total Liabilities |
557,912,510.83 |
| Paid-In Capital(Or Share Stock) |
1,184,167,119.00 |
| Capital Surplus |
2,409,019,358.51 |
| Surplus Reserve |
585,620,202.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,000,457,575.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,178,349,105.02 |
| Owner's Equity（Stockholder's Equity） |
2,178,349,105.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,736,261,615.85 |
